Cerebral Palsy (CP)2 Year Old, ARC's Story

ARC’s Story #

ARC is a two-year-old boy with cerebral palsy that is considered idiopathic, meaning it is not clear what caused his condition to develop. There were no notable complications during the pregnancy itself, but he was born at term after 37 weeks with an obstructed labor and the delivery that was assisted by forceps. As ARC grew, his difficulties with communicating and moving became increasingly apparent. He was diagnosed with cerebral palsy with spastic quadriparesis, indicating the presence of muscle stiffness in both arms and legs, and exhibited both language and motor development delays. 

After receiving the NeuroCytonix cerebral palsy protocol for 28 consecutive days, ARC demonstrated statistically significant improvements in several key behavioral and quality of life as measured by Pediatric Evaluation of Disability Inventory (PEDI), the Pediatric Quality of Life Inventory (PedsQL), and neuropsychological testing. 

Read on to learn more about how his condition responded to our cerebral palsy protocol.

How Cerebral Palsy Impacted ARC #

Our pediatric neurologist described ARC’s condition as cerebral palsy with spastic quadriparesis. He displayed both language and motor delays, meaning his speaking and movement abilities are less than is typical for his age. This is exemplified by his inability to say any words, walk, sit, or stand. His parents noted problems with his gross and fine motor skills, as he had poor head support, could not sit without support, and could not grasp objects with his hands. He also had yet to say his first word. It is possible that ARC’s difficult birth was a factor in his cerebral palsy, but it remains unclear exactly what caused it. Given his age and limited verbal communication, ARC was unable to communicate his perspective on his condition.

Previous Treatment for ARC #

Conventional treatment had not helped ARC much. 

Symptoms Prior to Receiving the Protocol #

Before the experimental therapy for cerebral palsy, ARC’s symptoms included the following:

• Spasticity in all four limbs (spastic quadriparesis)
• Inability to sit without support
• Inability to walk
• No verbal communication
• Poor head support
• Difficulty using hands to grasp objects

The NeuroCytonix Protocol for Cerebral Palsy #

ARC received our COFEPRIS-approved protocol for cerebral palsy designed to promote functional neurogenesis stimulation to repair the brain and help restore motor function. Our medical device delivered precise doses of radiofrequency waves to damaged or nonfunctioning cells with the goal of activating cell signaling pathways that regenerate brain cells and repair their broken communication networks.

We saw ARC at our Monterrey, Mexico clinical research center. 

ARC’s protocol followed these steps: 

1. First, an MRI (magnetic resonance imaging) scan was performed at a local hospital to visualize his brain structure and precisely locate where the radiofrequency signals should be focused. 
2. Then our neurologist studied the MRI scan data and tailored the protocol to ARC’s brain, and our technicians calibrated the device to deliver radiofrequency energy at the correct levels. 
3. The protocol was delivered for one hour a day for 28 consecutive days at our clinical center.

Life after the cerebral palsy protocol #

To evaluate the changes in ARC’s brain after receiving our cerebral palsy protocol, we used an imaging technique called diffusion tensor imaging (DTI). DTI uses MRI technology and software to model different structures in the body. We applied this technology in the brain using a technique called tractography that allows us to map neural tracts, the communication pathways in the brain. After the protocol, ARC’s tractography images showed an increase in all neural tracts measured and in the corticospinal tract specifically, a connective pathway associated with movement control. We performed an electroencephalogram (EEG) to measure the brain’s electrical activity before and after the protocol. There was no change in ARC’s EEG - both measurements were within the normal range.

Another assessment tool is the Modified Ashworth Scale which measures how stiff the muscles are in conditions like cerebral palsy. According to this scale, ARC had less spasticity in his left elbow, both wrists, and both ankles after the protocol. To assess changes in movement ability, we used the Gross Motor Function Classification System which assesses a child’s ability to do large movements involving the whole body, like crawling, walking, and jumping. ARC’s motor classification did not change, indicating that his improvements in mobility were not large enough to be detected by this evaluation tool.

To examine the protocol’s impact on disability, we used the PEDI, or Pediatric Evaluation of Disability Inventory. This tool assesses the daily functioning of children with disabilities, looking at their ability to do things like dressing, eating, and moving around. ARC improved in the Self Care, Mobility, and Social Function domains and in Caregiver Self Care (meaning he needed less help with self-care tasks). We also used the PedsQL, or Pediatric Quality of Life Inventory, a tool for measuring the overall well-being and quality of life in children and teenagers. ARC’s evaluation showed improvement in three areas after the protocol: Problems with Movement and Balance, Problems with Fatigue, and Problems with Eating Activities.

Beyond these assessments, ARC also improved in his abilities and quality of life following the protocol, including: 

• Better head support, back posture when sitting with support, and less help needed to stay seated.
• Greater ability to move both hands.
• Greater ability to chew and swallow food.
• Increase in vocalizing and smiling, communicating through gestures, and following directions.
• Improved cooperation when changing clothes and communicating about a dirty diaper.
• Improved mobility with greater strength in all four limbs leading to greater crawling abilities.

Our pediatric neurologist reports that ARC’s parents are elated with the results of this treatment. His quality of life has improved, without adverse events observed.

Contact us if you or a loved one are interested in receiving our CP protocol